Dyne therapeutics competitors

WebApr 7, 2024 · Summary Competitors Valuation Apr 7, 2024. ... Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is ... WebModerna Inc. stock outperforms competitors on strong trading day. MRNA +3.87% COMP +1.97%. MarketWatch · 2 days ago. Analyst. ... Dyne Therapeutics Inc. is a muscle disease company. The Company ...

Dyne Therapeutics Inc Ordinary Shares DYN Stock Quote

WebFind contact information for Dyne Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and Dyne Therapeutics's email format. ... Dyne Therapeutics Top Competitors. Company Employees Revenue Top technologies; Akouos. 57: $19.2 M: Generation Bio. 106: $18.5 M: Leap Therapeutics. … WebDyne Therapeutics’s Profile, Revenue and Employees. Dyne is a biotechnology company that develops and commercializes therapeutics for the treatment of genetic diseases. Dyne Therapeutics’s primary competitors include Avidity Biosciences, Sarepta Therapeutics, Neurana and 6 more. inception hulu https://kadousonline.com

Dyne Therapeutics Company Profile Management and …

WebOct 2, 2024 · Dyne Therapeutics Competitors. There are no companies similar to Dyne Therapeutics Dyne Therapeutics Related Companies. ... No industry vertical has been recorded for Dyne Therapeutics View All. Dyne Therapeutics Recommended Market Profiles (6) Telemedicine. 10,000 or More employees. 19 companies. WebDyne Therapeutics has 5 employees at their 1 location and $165 m in total funding,. See insights on Dyne Therapeutics including office locations, competitors, revenue, … WebApr 6, 2024 · 91,5%. More Financials. Company. Dyne Therapeutics Inc. is a muscle disease company. The Company is focused on advancing therapeutics for patients with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases. inception i3d

Dyne Therapeutics Company Profile Management and …

Category:Dyne Therapeutics Presents New In Vivo Data from DYNE-101

Tags:Dyne therapeutics competitors

Dyne therapeutics competitors

Dyne Therapeutics - DYN Stock Forecast, Price & News

WebFind company research, competitor information, contact details & financial data for Dyne Therapeutics, Inc. of Waltham, MA. Get the latest business insights from Dun & … WebMay 16, 2024 · DYNE-101 is designed to enable targeted delivery to muscle tissue and address the genetic basis of the disease. The new data being presented during ASGCT evaluated monthly repeat doses of DYNE-101 ...

Dyne therapeutics competitors

Did you know?

WebFind real-time DYN - Dyne Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. DYN - Dyne Therapeutics Inc Stock quote - … WebApr 4, 2024 · Dyne Therapeutics currently has a consensus target price of $25.83, suggesting a potential upside of 133.79%. Given Dyne Therapeutics’ higher possible upside, equities analysts plainly believe ...

WebDyne Therapeutics is a public company that has been in the industry for 6 years. The company currently specializes in the Biotechnology, Biotechnology, Pharmaceuticals areas. The position of the President & CEO is occupied by Joshua Brumm. Its headquarters is located at Waltham, Massachusetts, USA. The number of employees ranges from 25 to … WebApr 4, 2024 · 5 brokerages have issued twelve-month target prices for Dyne Therapeutics' shares. Their DYN share price forecasts range from $18.00 to $34.00. On average, they …

WebDyne Therapeutics Inc 's competitive profile, comparisons of quarterly results to its competitors, by sales, income, profitability, market share by products and services - … WebFeb 9, 2024 · Competitors: Unknown. Dyne Therapeutics Reviews ... Glassdoor gives you an inside look at what it's like to work at Dyne Therapeutics, including salaries, …

WebThe Competitors page allows you to view information for other symbols found in the same sector. In the table, you'll find all the components (individual stock symbols) found in that …

WebFeb 9, 2024 · Competitors: Unknown. Dyne Therapeutics Reviews ... Glassdoor gives you an inside look at what it's like to work at Dyne Therapeutics, including salaries, reviews, office photos, and more. This is the Dyne Therapeutics company profile. All content is posted anonymously by employees working at Dyne Therapeutics. income relief home improvementWebDec 30, 2024 · Peers & Competitors. Follow $11.59 0.19 (+1.67%) 3:59 PM 12/30/22. ... Dyne Therapeutics, Inc. (DYN) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability ... income renew car insuranceWebNov 3, 2024 · Cash position: Cash, cash equivalents and marketable securities were $248.1 million as of September 30, 2024, which is anticipated to fund operations through 2024. Research and development (R&D) expenses: R&D expenses were $34.7 million for the quarter ended September 30, 2024, compared to $36.5 million for the quarter ended … inception hypothesisinception how longWebDyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary ... income relief meaningWebDyne Therapeutics closed its last funding round on Jan 21, 2024 from a Post-IPO Equity round. Who are Dyne Therapeutics 's competitors? Alternatives and possible … income rent limits archWebMar 20, 2024 · Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically … inception ibd